Stroke, Vol 22, 1345-1352, Copyright © 1991 by American Heart Association
PD Lyden and GT Lau
BACKGROUND: To judge the efficacy of new, putative stroke therapies, we
need a method to measure neurological deficit accurately in groups of
patients before and after treatment. No single measurement technique has
yet proven to be universally acceptable, but one approach is the use of
rating instruments that summarize the neurological deficit found on
clinical examination. Currently, stroke assessment scales may be based on
the examination of physical deficits, an inventory of activities of daily
living, or a global evaluation of functional outcome. SUMMARY OF REVIEW:
Scientific methods for authenticating stroke scales are available in the
psychometric and statistical literature. We review currently available
stroke scales for their validity and reliability and propose investigations
needed to refine further the standardized measurement of neurological
deficit following stroke. CONCLUSIONS: We suggest that clinical stroke
trials include a physical deficit scale and a global rating during the
acute phase and that an activities of daily living scale be added at later
points in recovery.
ARTICLES
A critical appraisal of stroke evaluation and rating scales
Department of Neurosciences, UCSD School of Medicine, La Jolla 92093- 0608.
This article has been cited by other articles:
![]() |
N. Yozbatiran, L. Der-Yeghiaian, and S. C. Cramer A Standardized Approach to Performing the Action Research Arm Test Neurorehabil Neural Repair, February 1, 2008; 22(1): 78 - 90. [Abstract] [PDF] |
||||
![]() |
S. K. Schiemanck, G. Kwakkel, M. W. M. Post, and A. J. H. Prevo Predictive Value of Ischemic Lesion Volume Assessed With Magnetic Resonance Imaging for Neurological Deficits and Functional Outcome Poststroke: A Critical Review of the Literature. Neurorehabil Neural Repair, December 1, 2006; 20(4): 492 - 502. [Abstract] [PDF] |
||||
![]() |
F. B. Young, C. J. Weir, K. R. Lees, and for the GAIN International Trial Steering Committe Comparison of the National Institutes of Health Stroke Scale With Disability Outcome Measures in Acute Stroke Trials Stroke, October 1, 2005; 36(10): 2187 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Tirschwell, W.T. Longstreth Jr, K. J. Becker, R. E. Gammans Sr, L. A. Sabounjian, S. Hamilton, and L. B. Morgenstern Shortening the NIH Stroke Scale for Use in the Prehospital Setting Stroke, December 1, 2002; 33(12): 2801 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Tirschwell and W.T. Longstreth Jr Validating Administrative Data in Stroke Research Stroke, October 1, 2002; 33(10): 2465 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Meyer, T. M. Hemmen, C. M. Jackson, and P. D. Lyden Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Prospective Reliability and Validity Stroke, May 1, 2002; 33(5): 1261 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Albers, L. B. Goldstein, D. Hall, L. M. Lesko, and for the Aptiganel Acute Stroke Investigators Aptiganel Hydrochloride in Acute Ischemic Stroke: A Randomized Controlled Trial JAMA, December 5, 2001; 286(21): 2673 - 2682. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gotoh, Y. Terayama, and T. Amano Development of a Novel, Weighted, Quantifiable Stroke Scale: Japan Stroke Scale Stroke, August 1, 2001; 32(8): 1800 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
NINDS Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography Stroke, December 1, 2000; 31(12): 2912 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Dromerick, D. F. Edwards, and M. Hahn Does the Application of Constraint-Induced Movement Therapy During Acute Rehabilitation Reduce Arm Impairment After Ischemic Stroke? Stroke, December 1, 2000; 31(12): 2984 - 2988. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Duncan, H. S. Jorgensen, and D. T. Wade Outcome Measures in Acute Stroke Trials : A Systematic Review and Some Recommendations to Improve Practice Stroke, June 1, 2000; 31(6): 1429 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lyden, M. Lu, C. Jackson, J. Marler, R. Kothari, T. Brott, and J. Zivin Underlying Structure of the National Institutes of Health Stroke Scale : Results of a Factor Analysis Stroke, November 1, 1999; 30(11): 2347 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramasubbu, R. G. Robinson, A. J. Flint, T. Kosier, and T. R. Price Functional Impairment Associated With Acute Poststroke Depression: The Stroke Data Bank Study J Neuropsychiatry Clin Neurosci, February 1, 1998; 10(1): 26 - 33. [Abstract] [Full Text] |
||||
![]() |
L. D'Olhaberriague, I. Litvan, P. Mitsias, and H. H. Mansbach A Reappraisal of Reliability and Validity Studies in Stroke Stroke, December 1, 1996; 27(12): 2331 - 2336. [Abstract] [Full Text] |
||||
![]() |
M. Weinrich, S. Armentrout, and J. Reggia A Neural Model of Recovery from Lesions in the Somatosensory System Neurorehabil Neural Repair, January 1, 1995; 9(1): 25 - 32. [Abstract] [PDF] |
||||
![]() |
P. Gompertz, P. Pound, and S. Ebrahim Validity of the extended activities of daily living scale Clinical Rehabilitation, November 1, 1994; 8(4): 275 - 280. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |